VEGF-2 receptor antagonist peptides (Procter & Gamble)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVEGF-2 receptor antagonist peptides (Procter & Gamble)
Drug Alias NameVEGF-2 receptor antagonist peptides (P&G)angiogenesis inhibitors (Procter & Gamble)angiogenesis inhibitors (P&G)PGE-1439796
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcter & Gamble Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcter & Gamble Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A